Gilead Sciences, Inc. : Gilead Sciences to Present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16

Webcast Available Through Gilead Corporate Website

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas.

Kevin Young CBE, Gilead's Executive Vice President, Commercial Operations, and Robin Washington, Gilead's Senior Vice President and Chief Financial Officer, will provide an overview of the company at the Bank of America Merrill Lynch conference on Wednesday, May 16 at 3:40 p.m. Pacific Time (6:40 p.m. Eastern Time).

To access the live webcast or a replay via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Gilead Sciences, Inc.
Patrick O?Brien, 650-522-1936
Investor Relations

Partner Area